Thursday, May 1, 2008
8:30 a.m. - 3 p.m.
The escalating cost of medical care in the United States is of
growing concern to all. One of the reasons cited for the increase
in cost is the price of medicines and the length of time it takes
to bring a drug to market. At this colloquium five experts in
the disciplines necessary to move an exciting discovery made at the
laboratory bench to use in clinics at the bedside, will discuss
issues and potential improvements in their fields. The areas
to be discussed are research and development, translational
medicine, clinical trials, patents, and bringing a product to
market. This colloquium is targeted to employees of
biotechnology companies and members of college and university
faculties in the life sciences. The aim is to bring
participants in the biotechnology workforce development community
together to bring about a greater understanding of the
current reality in the biotechnology industry.
Colloquium
Schedule
Registration Form
Invited Speakers
- Dr.
David Epstein, Vice President, Oncology Research, OSI
Pharmaceuticals, Inc.
- Roy
L. Silverstein, M.D., Chairman, Department of Cell Biology,
Vice Chair for Translational Research, Lerner Research Institute,
Cleveland Clinic; Professor of Molecular Medicine, Case School of
Medicine
- Sharon
Nachman, M.D., Professor of Pediatrics, Associate Dean for
Research Stony Brook University School of Medicine, State
University of New York at Stony Brook
- Seth
Fidel, Ph.D., J.D., Partner, Cantor Colburn LLC
- Daniel
B. Yarosh, Ph.D., President and Chairman of the Board, AGI
Dermatics
Location
St. John’s
University
Council Hall
8000 Utopia Parkway
Queens, NY 11439
More Information
Diana C. Bartelt, Ph.D.
Associate Professor of Biological Sciences
Director, Institute for Biotechnology
St. John's University
barteltd@stjohns.edu
Sponsors
St. John's University Institute for Biotechnology
OSI Pharmaceuticals, Inc.